Loading...
XNASNUTX
Market cap167mUSD
Jan 10, Last price  
30.88USD
1D
-2.56%
1Q
56.04%
IPO
-92.28%
Name

Nutex Health Inc

Chart & Performance

D1W1MN
XNAS:NUTX chart
P/E
—
P/S
0.68
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
-42.78%
Rev. gr., 5y
385.96%
Revenues
248m
+12.93%
220,4691,266,3602,548,6530053,64791,37397,057,120273,422,221331,531,311219,294,306247,646,316
Net income
-46m
L-89.42%
605,288158,137-383,39383,809-7,432,241582,062-2,814,24516,483,467105,969,885132,593,328-432,739,618-45,786,614
CFO
1m
-97.52%
0-889,104-664,57444,907-274,223-714,623-480,04912,124,66481,264,270173,432,48650,607,1081,256,452
Earnings
Mar 26, 2025

Profile

Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
URL
https://www.nutexhealth.com/
IPO date
Mar 18, 2011
Employees
800
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
247,646
12.93%
219,294
-33.85%
Cost of revenue
248,938
223,873
Unusual Expense (Income)
NOPBT
(1,292)
(4,578)
NOPBT Margin
Operating Taxes
(5,067)
13,091
Tax Rate
NOPAT
3,776
(17,669)
Net income
(45,787)
-89.42%
(432,740)
-426.37%
Dividends
(51,232)
Dividend yield
6.37%
Proceeds from repurchase of equity
4,119
BB yield
-0.51%
Debt
Debt current
20,076
21,092
Long-term debt
490,942
475,090
Deferred revenue
23,051
Other long-term liabilities
(23,051)
Net debt
489,017
461,927
Cash flow
Cash from operating activities
1,256
50,607
CAPEX
(9,497)
(14,632)
Cash from investing activities
(11,240)
(4,337)
Cash from financing activities
(2,270)
(48,133)
FCF
28,879
(11,034)
Balance
Cash
22,002
34,255
Long term investments
Excess cash
9,620
23,291
Stockholders' equity
(390,743)
(338,171)
Invested Capital
745,606
724,670
ROIC
0.51%
ROCE
EV
Common stock shares outstanding
4,408
42,325
Price
1.80
-90.53%
19.00
 
Market cap
7,935
-99.01%
804,179
 
EV
514,605
1,290,570
EBITDA
16,300
8,553
EV/EBITDA
31.57
150.89
Interest
16,318
12,490
Interest/NOPBT